Concepedia

Author

Ulrich Julius

University Hospital Carl Gustav CarusORCID

Also Known As

DIS-Gruppe, E. Bergene, Hrsg Fischer, J. Ringel, J. Schulze, Julius, Ulrich, Maria Heide, T. Zimmermann, U JULIUS, U Julius

294

Publications

5.5K

Citations

34

H-Index

132

Concepts

All Affiliations

University Hospital Carl Gustav CarusTechnische Universität DresdenKempten University of Applied SciencesKlinik und Poliklinik für Psychotherapie und PsychosomatikAgaplesion Markus Hospital
UJ

About

Ulrich Julius is an author at University Hospital Carl Gustav Carus specializing in medicine, atherosclerosis, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

47

2.7K

2

Health Sciences

18

23

843

3

Public Health

14

23

1.6K

4

Social Sciences

2

2

31

5

Nursing

1

1

17

Ulrich Julius

×

84

Publications

4.3K

Citations

30

H-Index

YearCitations

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

M Hanefeld, Sven Fischer, Ulrich Julius,

Diabetologia

1996

879

Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease

Josef Leebmann, E. Roeseler, Ulrich Julius,

Circulation

2013

313

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons,

The Lancet

2021

285

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease

E. Roeseler, Ulrich Julius, Franz Heigl,

Arteriosclerosis Thrombosis and Vascular Biology

2016

211

Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Ioanna Gouni‐Berthold, Veronica J. Alexander, Qingqing Yang,

The Lancet Diabetes & Endocrinology

2021

211

Diabetes Intervention Study: Multi-Intervention Trial in Newly Diagnosed NIDDM

M Hanefeld, Sabine Fischer, H Schmechel,

Diabetes Care

1991

168

Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass

Sabine Fischer, M Hanefeld, Steven M. Haffner,

Acta Diabetologica

2002

160

In Vivo Evidence for Increased Oxidation of Circulating LDL in Impaired Glucose Tolerance

Steffi Kopprasch, Jens Pietzsch, Eberhard Kuhlisch,

Diabetes

2002

96

Evaluation of a Diabetes Management System Based on Practice Guidelines, Integrated Care, and Continuous Quality Management in a Federal State of Germany

Ulrike Rothe, Gabriele Müller, Peter E. H. Schwarz,

Diabetes Care

2008

93

In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.

Jens Pietzsch, Ulrich Julius, S. Nitzsche,

Diabetes

1998

85

Page 1